EPG Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
EPG Wealth Management's MRNA Position: Q3 2023 in Review
EPG Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 4,390 shares — an estimated $533K sold.
EPG Wealth Management first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $639K in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.
- EPG Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
- EPG Wealth Management sold 4,390 Moderna shares in Q3 2023, an estimated $533K.
- EPG Wealth Management first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
- EPG Wealth Management's Moderna position peaked at $639K in Q1 2023.
- 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.
Based on EPG Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.